Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
TAG-72 Antibody (CA72/733), FITC, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP234591F
Description
TAG-72 Monoclonal specifically detects TAG-72 in Human, Rat, Bovine, Canine samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
TAG-72 | |
Monoclonal | |
FITC | |
PBS with 0.05% Sodium Azide | |
Mouse | |
Protein A or G purified | |
RUO | |
Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This monoclonal antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. | |
Store at 4°C in the dark. |
Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
CA72/733 | |
Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
CA 72-4, Protein TAG-72, tag 72, tag-72 Protein TAG-72 | |
Recombinant human TAG-72 protein | |
0.1 mL | |
Primary | |
Human, Rat, Bovine, Canine | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction